Lipocine

Lipocine Dividend Coverage

Dividend Coverage Ratio of Lipocine (LPCN) as of Nov 5, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Lipocine is 2026 - . Dividend Coverage Ratio of Lipocine was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lipocine Stock analysis

What does Lipocine do? Lipocine Inc., based in Salt Lake City, Utah, is a clinical-stage biopharmaceutical company specializing in developing oral drug delivery solutions. The company focuses on enhancing bioavailability and reducing side effects through its proprietary technology, with lead candidates including TLANDO for testosterone replacement and pipeline products targeting NASH and other conditions. Listed on March 21, 2014, Lipocine operates with a team of 14 employees in the Health Care sector. Lipocine is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lipocine stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Lipocine since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Lipocine historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Lipocine

All Key Metrics — Lipocine